Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes

Leukemia

Volumn 11, Issue 12, 1997, Pages 2049-2054

  Kitagawa, M ^a,c   Saito, I ^b   Kuwata, T ^a   Yoshida, S ^c   Yamaguchi, S ^c   Takahashi, M ^c   Tanizawa, T ^c   Kamiyama, R ^c   Hirokawa, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone marrow; IFN ; Immunohistochemistry; Myelodysplastic syndromes; RT PCR; TNF

Indexed keywords

CD68 ANTIGEN; GAMMA INTERFERON; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031464758     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400844     Document Type: Article

References (15)

1. Delacretaz F, Schmidt P-M, Piguet D, Bachmann F, Costa J. The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987; 87: 180-186.
2. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 1985; 38: 1201-1217.
3. Kitagawa M, Kamiyama R, Takemura T, Kasuga T. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Arch B 1989; 57: 47-53.
4. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin E, Rifkin S, Alston D, Hernandez B, Shar R, Kaizer H, Gregory S. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol 1996; 63: 265-278.
5. Sachs L. The control of hematopoiesis and leukemia: from basic biology to the clinic. Proc Natl Acad Sci USA 1996; 93: 4742-4749.
6. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factor. Blood 1986; 67: 257-267.
7. Bot FJ, Schipper P, Breeders L, Delwel R, Kaushansky K, Loewenberg B. Interleukin-1 α also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells. Blood 1990;76: 307-311.
8. Ulich TR, del Castillo J, Guo K, Souza L. The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation. Am J Pathol 1989; 134: 149-159.
9. Slack JL, Nemunaitis J, Andrews DF, Singer JW. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40. Blood 1990; 75: 2319-2327.
10. Peschel C, Green I, Paul WE. Interleukin-4 induces a substance in bone marrow stromal cells that reversibly inhibits factor-dependent and factor-independent cell proliferation. Blood 1989; 73: 1130-1141.
11. + hematopoietic progenitor cells. Blood 1990; 75: 2292-2298.
12. Murase T, Hotta T, Saito H, Ohno R. Effect of recombinant tumor necrosis factor on the colony growth of human leukemia progenitor cells and hematopoietic progenitor cells. Blood 1987; 69: 467-472.
13. Young MRI, Young ME, Wright MA. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-aα synergistically reduce suppressor cell activity. Int J Cancer 1990; 46: 245-250.
14. Slordal L, Warren DJ, Moore MAS. Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy. Cancer Res 1990; 50: 4216-4220.
15. Lindemann A, Ludwig W-D, Oster W, Mertelsmann R, Herrmann F. High-level secretion of tumor necrosis factor-α contributes to hematopoietic failure in hairy cell leukemia. Blood 1989; 73: 880-884.